Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder;Door aripiprazol geïnduceerd parkinsonisme bij een 64-jarige patiente met een bipolaire stoornis

Tijdschrift voor Psychiatrie

Volumn 53, Issue 5, 2011, Pages 299-303

  De Schutter, P ^a   Bouckaert, F ^a   Peuskens, J ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Aripiprazole; Elderly; Parkinsonism

Indexed keywords

ARIPIPRAZOLE;

ADULT; BIPOLAR DISORDER; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; NEUROPATHOLOGY; PARKINSONISM; PSYCHOPHARMACOTHERAPY; REVIEW;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; HUMANS; MIDDLE AGED; PARKINSON DISEASE; PIPERAZINES; QUINOLONES;

EID: 79955988884     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Ashiwel S, Friedman E. Antipsychotic drugs. In: Roberts J, Snyder D, Friedman E, red. Handbook of pharmacology of aging. Boca Raton: CRC press; 1996. p. 163-72.
2. Caligiuri MP, Jeste DV, Lacro JP. Antipsychotic-induced movement disorders in the elderly. Epidemiology and treatment recommendations. Drugs Aging 2000;17:363-84.
3. Castberg I, Spigset O. Effects of comedication on the serum levels of aripiprazole: evidence from a routine therapeutic drug monitoring service. Pharmacopsychiatry 2007;40:107-10. (Pubitemid 46910381)
4. Esper CD, Factor SA. Failure of recognition of drug-induced parkinsonisme in the elderly. Mov Disord 2008;23:401-4.
5. Fountoulakis KN, Vieta E. Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review. Ann Gen Psychiatry 2009;8:16.
6. Gao K, Kemp DE, Ganocy SJ, Gajwani P, Xia G, Calabrese JR. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J Clin Psychopharmacol 2008;28:203-9. (Pubitemid 351417126)
7. Gareri P, De Fazio P, De Fazio S, Marigliano N, Ibbadu GF, De Sarro G. Adverse effects of atypical antipsychotics in the elderly. A review. Drugs Aging 2006;23:937-56. (Pubitemid 44936061)
8. Gentile S. Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder. J Clin Psychopharmacol 2007;27:35-45. (Pubitemid 46105761)
9. Ghaemi SN, Hsu DJ, Rosenquist KJ, Pardo TB, Goodwin FK. Extrapyramidal side effects with atypical neuroleptics in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:209-13. (Pubitemid 43288060)
10. Haddad PM, Sharma SG. Adverse effects of atypical antipsychotics: differential riskand clinical implications. CNS Drugs 2007;21:911-36. (Pubitemid 47557106)
11. Harten PN van. Acute bewegingsstoornissen door medicijnen. Tijdschr Psychiatr 2003;45:251-63.
12. Koener B, Hermans E, Maloteaux JM, Jean-Jean A, Constant EL. Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole. Am J Psychiatry 2007;164:1437-8. (Pubitemid 47461149)
13. Keck PE, McEIroy SL. Aripiprazole: A partial dopamine D2 receptor agonist antipsychotic. Expert Opin Investig Drugs 2003;12:655-62.
14. Keck PE, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, e.a. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 2007;68:1480-91. (Pubitemid 350073394)
15. Mailman RB, Murthy V. Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? Curr Pharm Des 2010;16:488-501.
16. Mamo D, Graff A, Mizrahi R, Shammi CM, Romeyer F, Kapur S. Differential effects of aripiprazole on D2, 5-HT2 and 5-HT1a receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry 2007;164:1411-7. (Pubitemid 47461142)
17. Pae CU. A review of the safety and tolerability of aripiprazole. Expert Opin Drug Saf 2009;8:373-86.
18. Swainston Harrison T, Perry CM. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Drugs 2004;64:1715-36. (Pubitemid 39128008)
19. Vieta E, Bourin M, Sanchez R, Marcus R, Stock E, McQuade R, et al. Effectiveness of aripiprazole versus halopcridol in acute bipolar mania: double-blind randomised comparative 12-week trial. Br J Psychiatry 2005;187:235-42. (Pubitemid 41306104)
20. Volkow ND, Gur RC, Wang G, Fowler JS, Moberg PJ, Ding Y, et al. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 1998;155:344-9. (Pubitemid 28114890)
21. Weiden PJ. EPS profiles: the atypical antipsychotics are not all the same. J Psychiatr Pract 2007;13:13-24. (Pubitemid 46148428)
22. Zacher JL, Hatchett AD. Aripiprazole-induced movement disorder. Am J Psychiatry 2006;163:160-1.